Jeanne Menez-Jamet

Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001

Eleni‐Kyriaki Vetsika, Georgios Konsolakis, Despoina Aggouraki et al. · Cancer Immunology Immunotherapy · 2011 · 44 citations · Full text

Medicine, Immunology, Oncology +16

A Multicenter Randomized Phase IIb Efficacy Study of Vx-001, a Peptide-Based Cancer Vaccine as Maintenance Treatment in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics

Vassilis Georgoulias, Jean‐Yves Douillard, David Khayat et al. · Clinical Lung Cancer · 2013 · 23 citations

Medicine, Oncology, Immunization +16

CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope

Sébastien Cornet, Jeanne Menez-Jamet, François A. Lemonnier et al. · Vaccine · 2005 · 18 citations

Life Sciences, Immunology, Immunization +15

Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in “Immune Desert” NSCLC

Ioannis S. Pateras, Αthanasios Kotsakis, Margaritis Avgeris et al. · Cancers · 2021 · 13 citations · Full text

Medicine, Immunology, Oncology +17